Aniset L, Kalenka A
Klinik für Anästhesiologie und Operative Intensivmedizin, Universitätsmedizin Mannheim.
Anaesthesist. 2010 Apr;59(4):327-32. doi: 10.1007/s00101-010-1699-5.
The successful application of a pumpless extracorporeal lung assist procedure ("interventional lung assist, iLA) in three cases of severe refractory status asthmaticus, which could not be solved with conventional pharmacological and respiratory therapy is reported. After an individual risk-benefit analysis such a therapy can be used to reduce lung injury due to invasive mechanical ventilation. Because of the complexity of this therapy it should only be applied in special medical centers with sufficient experience in dealing with extracorporeal lung assist procedures.
据报道,无泵体外肺辅助程序(“介入性肺辅助,iLA”)在三例严重难治性哮喘持续状态患者中成功应用,这些患者无法通过传统的药物和呼吸治疗解决。经过个体风险效益分析,这种治疗可用于减少有创机械通气导致的肺损伤。由于这种治疗的复杂性,它应仅在有足够体外肺辅助程序处理经验的特殊医疗中心应用。